Patents > Guidance, Tools, and Manuals > Classification > Class Schedule

Class Numbers & Titles   | Class Numbers Only   | USPC Index   | International   | HELP

You are viewing a USPC Schedule.

200

NATURAL RESINS OR DERIVATIVES (E.G., WOOD OR PINE TAR; CATIVO RESIN DERIVATIVES, ETC.)

201

Shellac containing starting material used in process, or product thereof (e.g., lac, sticklac, seedlac, flake shellac, bleached shellac, etc.)

202

Cut wood starting material used in process, or product thereof (e.g., using pine stumps, chips, bark, etc., as starting material)

203

Plant sap or fossil starting material used in process, or product thereof (e.g., using copal, coal, amber, dammar, etc., as starting material)

204

Pine oleoresin starting material used in process, or product thereof (e.g., using gum turpentine, pine gum, pine resin, etc., as starting material)

205

Recovery of tall oil or derivatives from papermaking waste, purification of tall oil, or separation of components of tall oil; or product thereof (e.g., separation of rosin, fatty acids, sterols, etc.; decolorizing, etc.)

206

Organic sulfur or nitrogen containing material used in the process, or product thereof

207

Esterification used in the process, or product thereof

208

Inorganic material used in the process, or product thereof (e.g., using sulfuric acid, boric acid, etc.)

209

Phosphorus or heavy metal containing material, elemental hydrogen, sulfur dioxide, or carbon dioxide used in the process, or product thereof

210

Rosin or derivative used as starting material in process, or product thereof (e.g., using gum rosin, wood rosin, solid tall oil rosin, etc.)

211

Polymerization or product thereof (e.g., dimer rosin, etc.)

212

Chemical treatment or color modification of polymerized rosin or derivative, or product thereof (e.g., hydrogenation or esterification of polymerized rosin; removal of color bodies from polymerized rosin, etc.)

213

Boron or phosphorus containing material used in the process, or product thereof

214

Diels-Alder adducts (e.g., of maleic anhydride, fumaric acid, etc., with conjugated dienes, such as rosin acids, terpenes, etc.)

215

Esterification of rosin or derivative via carboxyl group, or product thereof

216

Chemical treatment or color modification of esterified rosin or derivative, or product thereof (e.g., partial saponification of rosin triglycerides; removal of color bodies from rosin esters, etc.)

217

Oxygen containing ring or halogen containing material used in the esterification, or product thereof (e.g., using alkylene oxides, polysaccharides, alkyl halides, etc.)

218

Polyhydroxy material used in the esterification, or product thereof (e.g., forming ester gum, etc.)

219

Sulfur, selenium, or tellurium containing material used in the process, or product thereof (e.g., disproportionation of rosin, etc.)

220

The sulfur, selenium, or tellurium containing material is inorganic

221

Nitrogen containing material used in the process, or product thereof

222

The nitrogen containing material is inorganic

223

Hydrogenation or product thereof (e.g., forming dihydro rosin acids; rosinyl alcohol or derivatives; etc.)

224

Metal containing material used to form salts of rosin acids, or product thereof

225

Alkali metal containing material (i.e., Li, Na, K, Rb or Cs)

226

Heat treatment of rosin or derivative in the absence of nonrosin organic reactants, or product thereof (e.g., forming rosin oil; disproportionated, dehydrogenated, or isomerized rosin; etc.)

227

Metal, halogen, or silicon containing material used in the process, or product thereof (e.g., using clay, zeolites, etc.)

228

Purification process or product thereof

229

Immiscible solvents used in the process, or product thereof

230

Tall oil or derivative used as starting material in process, or product thereof (e.g., metal salts of tall oil fatty acids; tall oil pitch, etc.) dehydrogenated, or isomerized rosin; etc.)

231

Nitrogen containing material used in the process, or product thereof

232

Esterification of tall oil acids, or product thereof

233

Sulfur, boron, phosphorus, or iodine containing material used in the process, or product thereof

300

PEPTIDES OF 3 TO 100 AMINO ACID RESIDUES

301

Thymopoietin or Lipotropin; related peptides

302

Endorphin and Enkephalin; related peptides

303

Insulin; related peptides

304

Metal complexes, e.g., Zn-insulin, etc.

305

Isolation or purification

306

Corticotropin (ATCH); related peptides

307

Calcitonin; related peptides

308

Glucagon; related peptides

309

Secretin or gastrin; related peptides

310

Gramicidin or Tyrocidin; related peptides

311

Somatostatin (SRIF); related peptides

312

Melanotropin (MSH) or eledoisin; related peptides

313

Lutenizing hormone releasing factor (LRF); related peptides

314

Bradykinin; kallidin; related peptides

315

Oxytocin; vasopressin; related peptides

316

Angiotensin; related peptides

317

Cyclic peptides

318

The cyclisation occurring through the 4-amino radical of 2,4-diamino butanoic acid

319

Polymyxin; related peptides

320

Bacitracin; related peptides

321

Containing only normal peptide links in the ring, i.e., homodetic cyclic peptides

322

Peptides containing saccharide radicals, e.g., bleomycins, etc.

323

Peptides with at least one nonpeptide bond other than a disulfide bond joining two or more sequences of amino acid residues, e.g., homomeric heterodectic peptide other than cyclic disulfide, depsipeptides, etc.

324

25 or more amino acid residues in defined sequence

325

24 amino acid residues in defined sequence

326

15 to 23 amino acid residues in defined sequence

327

11 to 14 amino acid residues in defined sequence

328

8 to 10 amino acid residues in defined sequence

329

6 to 7 amino acid residues in defined sequence

330

4 to 5 amino acid residues in defined sequence

331

Tripeptides, e.g., tripeptide thyroliberin (TRH), melanostatin (MIF), etc.

332

Containing at least one abnormal peptide link, e.g., gamma peptide bonded, etc.

333

Synthesis of peptides

334

Polymer supported synthesis, e.g., solid phase synthesis, Merrifield synthesis, etc.

335

Protecting or removing protective groups, e.g., carboxyl group protection, etc.

336

Of side chain or sulfur containing group

337

Of amino group

338

Solution phase synthesis

339

Segment condensation, e.g., Ugi condensation, etc.

340

With phosphorus containing material

341

With use of carbonimide or imidiazole

342

Mixed anhydride synthesis

343

By hydrolysis

344

Separation or purification

345

Chemical aftertreatment, e.g., acylation, methylation, etc.

350

PROTEINS, I.E., MORE THAN 100 AMINO ACID RESIDUES

351

Lymphokines, e.g., interferons, interlukins, etc.

352

Phosphoproteins, e.g., phosvitin, vitellogenin, etc.

353

Scleroproteins, e.g., fibroin, elastin, silk, etc.

354

Gelatin

355

Separation, purification or synthesis

356

Collagen

357

Keratin

358

Nucleoproteins, e.g., chromatin, chromosomal proteins, histones, protamines, salmine, etc.

359

Lipoproteins, e.g., egg yolk proteins, cylomicrons, etc.

360

Casein or caseinate

361

Separation, purification or synthesis

362

Albumin

363

Serum albumin, e.g., BSA, HSA, etc.

364

Separation, purification or synthesis

365

Lactalbumin, e.g., milk source, etc.

366

Separation, purification or synthesis

367

Ovalalbumin, e.g., avidin, conalbumins, etc.

368

Separation, purification or synthesis

369

Separation, purification or synthesis

370

Plant proteins, e.g., derived from legumes, algae or lichens, etc.

371

Derived from fungi, e.g., yeasts, mushroom, etc.

372

Derived from grain, e.g., prolamines, etc.

373

Zein

374

Gluten or gliadin

375

Derived from wheat

376

Derived from corn

377

Derived from oil seed, e.g., cotton seed, rapeseed, sunflower, etc.

378

Derived from soybean

379

Derived from leafy green plants, e.g., alfalfa pollen, etc.

380

Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc.

381

Blood coagulation factors and fibrin, e.g., thromboplastin, etc.

382

Fibrin or fibrin intermediates, e.g., fibrinogen, etc.

383

Blood coagulation factor VIII, AHF

384

Blood coagulation factor II or factor II + VII + IX + X, i.e., prothrombin complex or factor

385

Hemoglobins or globins

386

Globulins

387.1

Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or adsorbed

387.2

Anti-idiotypic

387.3

Chimeric, mutated, or recombined hybrid (e.g., bifunctional, bispecific, rodent-human chimeric, single chain, rFv, immunoglobulin fusion protein, etc.)

387.5

Binds oligosaccharide structure

387.7

Binds expression product of cancer-related gene or fragment thereof (e.g., oncogene, proto-oncogene, etc.)

387.9

Binds specifically-identified amino acid sequence

388.1

Monoclonal

388.15

Human

388.2

Binds microorganism or normal or mutant component or product thereof (e.g., animal cell, cell-surface antigen, secretory product, etc.)

388.21

Binds nucleic acid or derivative or component thereof (e.g., DNA, RNA, DNA-RNA hybrid, nucleotide, nucleoside, carcinogen-DNA adduct, etc.)

388.22

Binds receptor (e.g., transferrin receptor, Fc receptor, dihydropyridine receptor, IL-2 receptor, etc.)

388.23

Binds lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, or intercellular mediator specific for a hematopoietic cell (e.g., interleukin, interferon, erythropoietin, etc.)

388.24

Binds hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, intragonadal regulatory protein, Mullerian inhibiting substance, inhibin, epidermal growth factor, nerve growth factor, dopamine, norepinephrine, etc.)

388.25

Binds plasma protein, serum protein, or fibrin (e.g., clotting factor, fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.)

388.26

Binds enzyme

388.3

Binds virus or component or product thereof (e.g., virus-associated antigen, etc.)

388.35

Binds retrovirus or component or product thereof (e.g., HIV, LAV, HTLV, etc.)

388.4

Binds bacterium or similar microorganism or component or product thereof (e.g., Stretococcus, Legionella, Mycoplasma, bacterium-associated antigen, exotoxin, etc.)

388.5

Binds fungus or plant cell or component or product thereof (e.g., fungus-associated antigen, etc.)

388.6

Binds parasitic protozoan or metazoan cell or component or product thereof (e.g., Dirofilaria, Eimeria, Coccidia, Trichinella, parasite cell-surface antigen, etc.)

388.7

Binds hematopoietic cell or component or product thereof (e.g., erythrocyte granulocyte, macrophage, monocyte, platelet, myelogenous leukemia cell, bone marrow stem cell, granulocytic cell-surface antigen, hemoglobin, thrombospondin, glycophorin, etc.)

388.73

Binds lymphocytic or lymphocytic-like cell or component or product thereof (e.g., B cell, B-lineage bone marrow cell, null cell, natural killer cell, B-lymphoblastoid cell, B-lineage acute lymphoblastic leukemia cell, B-lymphocytic cell-surface antigen, etc.)

388.75

Binds T-lymphocytic cell or component or product thereof (e.g., T cell, thymocyte, T-lineage bone marrow cell, T-lymphoblastoid cell, T-lineage acute lymphoblastic leukemia cell, T-lymphocytic cell-surface antigen, etc.)

388.8

Binds cancer cell or component or product thereof (e.g., cell-surface antigen, etc.)

388.85

Binds antigen characterized by name or molecular weight (e.g., CEA, NCA, CC glycoprotein, melanoma gp 150 antigen, etc.)

388.9

Binds drug, hapten, hapten--carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.)

389.1

Polyclonal antibody or immunogloblin of identified binding specificity

389.2

Binds hormone, lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, glucagon, cardiodilatin, interleukin, interferon, norepinephrine, epinephrine, acetylcholine, etc.)

389.3

Binds plasma protein, serum protein, or fibrin (e.g., clotting factor, fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.)

389.4

Binds virus or component or product thereof (e.g., virus-associated antigen, etc.)

389.5

Binds bacterium or similar microorganism or component or product thereof (e.g., Pseudomonas, Chlamydia, Clostridium, bacterium-associated antigen, etc.)

389.6

Binds hematopoietic cell or component or product thereof (e.g., erythrocyte, granulocyte, bone marrow cell, lymphocyte, leukemic cell, hematopoietic cell-surface antigen, hemoglobin, etc.)

389.7

Binds cancer cell or component or product thereof (e.g., cell-surface antigen, etc.)

389.8

Binds drug, hapten, hapten-carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.)

390.1

Removing or inactivating virus or bacterium or component or product thereof (e.g., endotoxin, etc.)

390.5

Removing, dissociating, or preventing the formation of aggregated, denatured, fragmented, or polymerized immunoglobulin or antibody; or preventing or reducing complement fixation or binding; or reducing antigenicity; or removing, inactivating, or inhibiting contaminating plasma proteins (e.g., proteolytic enzymes, etc.)

391.1

Monoclonal or polyclonal antibody or immunoglobulin or fragment thereof that is conjugated or adsorbed (e.g., adsorbed to a solid support, etc.)

391.3

Conjugated to a detectable label or radioisotope or radionuclide or heavy metal-containing compound

391.5

Conjugated via a specifically-identified linking group, chelating group, coordination complex, coupling agent, or conjugation agent

391.7

Conjugated to a cytotoxic agent, drug, or other biologically-active substance

391.9

Conjugated via a specifically-identified linking group, coupling agent, or conjugation agent

392

Alpha globulins, e.g., ceruloplastin, haptoglobins, etc.

393

Antithrombin III

394

Beta globulins, e.g., transferrin, etc.

395

Glycoprotein, e.g., mucins, proteoglycans, etc.

396

Lectins, e.g., concanavalin, hemagglutinin, etc.

397

Glycoprotein hormones

398

Gonadatropins

399

Hormones, e.g., prolactin, thymosin, growth factors, etc.

400

Metal containing, e.g., chromoproteins, ferritin, ferredoxins, etc.

401

Cytochromes, e.g., chlorophyl, orgotein, etc.

402

Chemical modification or the reaction product thereof, e.g., covalent attachment or coupling, etc.

403

Protein is identified as an antigen, e.g., immunogenic carriers, etc.

404

Sulfur containing reactant

405

Nitrogen containing reactant

406

Oxygen containing reactant

407

Hydrolysis of protein

408

Sulfur containing reactant

409

Nitrogen containing reactant

410

Oxygen containing reactant

411

Oxygen containing is saccharide

412

Separation or purification

413

Immunological separation or affinity chromatography

414

Ultra filtration or osmosis

415

Selective absorbtion, e.g., Ca phosphate sorbents, etc.

416

Ion exchange

417

Chromatography or by septum selective as to material, e.g., gel filtration, molecular sieve dialysis, etc.

418

Precipitation

419

With added material

420

Inorganic

421

Polymeric, e.g., polyethylene glycol, etc.

422

Solvent extraction

423

Oxygenated material

424

Alcohol

425

Carboxyl containing

426

Hydrocarbon or halogenated hydrocarbon

427

Physical treatment

500

LIGNINS OR DERIVATIVES

501

Aldehyde, ketone or ozone reacted with a lignin or lignin containing substance, or product thereof

502

Compound which includes phenolic hydroxy or oxygen containing hetero ring reacted with a lignin or lignin containing substance, or product thereof

503

Hydrogenation of a lignin or lignin containing substance, or product thereof

504

Carboxylic acid anhydride, or a compound having halogen bonded directly to acyclic carbon by nonionic bonding, reacted with a lignin or lignin containing substance, or product thereof

505

Compound containing nitrogen attached directly or indirectly to carbon by nonionic bonding reacted with a lignin or lignin containing substance, or product therof

506

Heavy metal, aluminum, silicon or phosphorus containing

507

Processes utilizing an organic solvent or a compound having alcoholic hydroxy bonded directly to an acyclic carbon, or product thereof

800

ANTIHYPERTENSIVE PEPTIDES

801

PEPTIDE SWEETNERS

802

CHROMOGENIC OR LUMINESCENT PEPTIDES

806

ANTIGENIC PEPTIDES OR PROTEINS

807

HAPTEN CONJUGATED WITH PEPTIDE OR PROTEIN

808

MATERIALS AND PRODUCTS RELATED TO GENETIC ENGINEERING OR HYBRID OR FUSED CELL TECHNOLOGY, E.G., HYBRIDOMA, MONOCLONAL PRODUCTS, ETC.

809

Fused cells, e.g., hybridoma, etc.

810

CARRIER - BOUND OR IMMOBILIZED PEPTIDES OR PROTEINS AND THE PREPARATION THEREOF, E.G., BIOLOGICAL CELL OR CELL FRAGMENT AS CARRIER, ETC.

811

Peptides or proteins is immobilized on, or in, an inorganic carrier

812

Peptides or proteins is immobilized on, or in, an organic carrier

813

Carrier is a saccharide

814

Cellulose or derivatives thereof

815

Carrier is a synthetic polymer

816

Attached to the carrier via a bridging agent

817

Entrapped within the carrier, e.g., gel, hollow fibre, etc.

820

PROTEINS FROM MICRO-ORGANISMS

821

Separation of nucleic acid

822

Protozoa

823

Lower fungi, e.g., mold, etc.

824

Yeasts

825

Bacteria

826

Viruses

827

PROTEINS FROM MAMMALS OR BIRDS

828

Cancer

829

Blood

830

Plasma; serum

831

Cohn fractions

832

Milk; colostrum

833

Whey; cheese

834

Urine; urinary system

835

Kidney

836

Mucus; mucous glands; bursa; arthral fluid; spinal fluid

837

Lymph; lymph-glands; thymus

838

Marrow; spleen

839

Nerves; brain

840

Bones; tendons; teeth; cartilage

841

Muscles; heart

842

Skin; hair; nails; sebaceous glands; cerumen

843

Digestive system

844

Stomach; intestine

845

Pancreas

846

Liver

847

Bile

848

Lungs

849

Eyes; vessels; umbilical cord

850

Reproductive organs or embryos

851

Placenta; amniotic fluid

852

Sperm

853

Ovary; eggs; embryos

854

Glands

855

PROTEINS FROM ANIMALS OTHER THAN MAMMALS OR BIRDS

856

Snakes; venom

857

Fish; fish eggs; shell fish; crustacea

858

Insects; venom

859

WASTE, WASTE MATERIAL, REFUSE OR SLUDGE, E.G., EFFLUENTS, FECAL MATTER, ETC.

860

RENIN INHIBITORS

861

INVOLVING IGG3, IGG4, IGA, OR IGY

862

INVOLVING IGE OR IGD

863

INVOLVING IGM

864

Monoclonal

865

Human

866

INVOLVING IMMUNOGLOBULIN OR ANTIBODY FRAGMENT, (E.G., F(AB)'2, FAB', FAB, FV, FC, HEAVY CHAIN, LIGHT CHAIN, ETC.)

867

INVOLVING IMMUNOGLOBULIN OR ANTIBODY PRODUCED VIA RECOMBINANT DNA TECHNOLOGY

868

INVOLVING AUTOIMMUNITY, ALLERGY, IMMEDIATE HYPERSENSITIVITY, DELAYED HYPERSENSITIVITY, IMMUNOSUPPRESSION, OR IMMUNOTOLERANCE

This page is produced by the Office of Classification Support (Office of Patent Classification) for the Reference Tools Project.

Please send questions and comments to usptoinfo@uspto.gov .

Note: The Patent and Trademark Depository Library Program (PTDLP) administers a nationwide network of public, state and academic libraries designated as Patent and Trademark Depository Libraries authorized by 35 U.S.C. 13 to: Disseminate Patent and Trademark Information Support Diverse Intellectual Property Needs of the Public. PTDL Contact Information

Note: For information/comments on electronic information products, such as purchasing USPTO data, or to discuss system requirements for magnetic tape products, contact:

     Information Products Division -- U.S. Patent and Trademark Office Information Products Division Contact Information
     Or, browse their on-line catalog.

KEY: =online business system =fees =forms=help =laws/regulations =definition (glossary) The Inventors Assistance Center is available to help you on patent matters.Send questions about USPTO programs and services to the USPTO Contact Center (UCC). You can suggest USPTO webpages or material you would like featured on this section by E-mail to the webmaster@uspto.gov. While we cannot promise to accommodate all requests, your suggestions will be considered and may lead to other improvements on the website.